Summary & Overview
CPT 0955T: Removal of Totally Implantable Active Middle Ear Implant
CPT code 0955T denotes the surgical removal of all components of a totally implantable active middle ear hearing implant (AMEI). This explantation code captures a specialized otologic procedure that has implications for device management, post-implant care, and surgical billing. Nationally, accurate coding of device explantation affects claims processing, quality measurement, and longitudinal device registries.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for AMEI explantation, typical sites of service, and common billing considerations tied to the code definition. The publication summarizes benchmarks and payment patterns where available, highlights relevant policy updates affecting device explantation billing, and situates the code within otologic surgical service lines.
The report is intended to help coding professionals, revenue cycle managers, and clinical leaders understand how CPT code 0955T is used, what procedural scenarios it represents, and which payers are most relevant for coverage and claims adjudication. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 0955T describes the removal of all components of a totally implantable active middle ear hearing implant (AMEI). This procedure entails explantation of a fully implanted active middle ear device and all of its implanted components.
-
Service type: Surgical explantation of an active middle ear implant
-
Typical site of service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with a previously implanted totally implantable active middle ear hearing implant (AMEI) presents with device failure and persistent pain at the implant site. The patient reports decreased amplification and intermittent non-auditory sensations. Imaging and device interrogation confirm nonfunctional internal components with no feasible reprogramming or in-office corrective measures. After consultation, the otologist schedules operative removal of all components of the totally implantable AMEI under general anesthesia. The typical clinical workflow includes preoperative evaluation (history, physical exam, audiometry, device check, and imaging as indicated), informed consent documenting risks of explantation and possible hearing outcome changes, perioperative antibiotic prophylaxis as indicated, operative removal of the internal receiver-stimulator, fixation hardware, and any electrode or coupling elements, intraoperative hemostasis and wound closure, immediate postoperative recovery with pain control and wound care instructions, and scheduled follow-up for wound assessment and audiologic rehabilitation planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the explantation due to extensive scarring, complex dissection, or prolonged operative time and documentation supports unusual effort. |